Chelsea Therapeutics Internati… (NASDAQ:CHTP) Stock Price & News

biotech

Chelsea Moving on to the Revenue Stage of Its Cycle

Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) is finding a serious victory from its hypotension drug. Shares hit a 52-week high -- make that a three-year high -- after the company ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Analog Devices, Chelsea Therapeutics, Tesla, Westport, More

Earnings season is winding down and the markets have recovered from the January and early February selling. Investors and analysts alike are positioning themselves for the rest of this year. ...
Read Full Story »
biotech

Can Chelsea Live Up to Its Potential This Time?

Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) is on the leader board for percentage gains on Thursday, with a rise of 111% or so. It isn't even on news of a ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Intel, ExOne, GameStop, SodaStream and More

Earnings season is getting off to a start and analysts are still making many changes to their 2014 outlooks. Investors are still positioning their portfolios for 2014 at the same ...
Read Full Story »
Stock Split Image

Chelsea Therapeutics Rally — Speculation or Desperation?

Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) is rallying on Wednesday after a report in Seeking Alpha called its Northera, a treatment for symptomatic neurogenic hypotension in Parkinson's patients, a shoe-in for approval, ...
Read Full Story »
biotech

Chelsea Therapeutics Back on the Map in a Serious Way

When Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) announced that the U.S. Food & Drug Administration was going to allow the company to submit its market approval application for Northera using ...
Read Full Story »

Today’s Market Winners and Losers

In the abbrevated trading day just before July 4, the overall stock market is up slightly. The Dow Jones Industrial Average is up 0.2%, the Nasdaq is up 0.45% and the ...
Read Full Story »

24/7 Wall St. Closing Bell (AMZN, APOL, HFC, LVS, VZ, MOS, RHT, SN, SHAW, BBY, MY, RIMM, FINL, PHM, CHTP, MM)

Markets opened lower this morning but fought back on the day.  This morning’s report new unemployment benefits claims tamped down enthusiasm among investors (our coverage here). US natural gas inventories ...
Read Full Story »

Potential Deathblow for Chelsea (CHTP)

Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) is being beaten hard this morning.  News hit that the FDA has now rejected the company's Northera drug to treat low blood pressure for ...
Read Full Story »

24/7 Wall St. Closing Bell (AAPL, ADP, KFT, PG, MCO, LULU, ADGF, CHTP, AEO, BWS, CSIQ, CTIC, HOV, TRCR, MAG, BONT, P, VRML)

US stocks opened higher this morning following an in-line report from ADP on US employment gains. There was little economic news out today, but we can anticipate tomorrow’s report on ...
Read Full Story »

24/7 Wall St. Closing Bell (FSLR, MNST, TSL, ARMH, MAR, Y, CROX, DECK, MRVL, MCP, SPN, ANR, JCP, NEM, CHTP, BV, KCP, RBCN, KND)

After opening higher this morning, markets rebounded from an early dip following a better-than-expected reading on consumer confidence and a bullish report on US new home sales. But sellers took ...
Read Full Story »

Mid-day Movers (CHTP, BV, KCP, RBCN, KND)

Shortly after noon ET today, all three major US stock indexes are showing gains, with the DJIA up more than 24 points at about 13,009, the Nasdaq up nearly 12 ...
Read Full Story »

Morning Movers (CHTP, KCP, KND, RBCN, DECK)

The three major US equities indexes opened higher this morning but quickly lost steam ahead of the consumer sentiment and monthly new home sales reports. Action in Europe and Asia ...
Read Full Story »

24/7 Wall St. Closing Bell (ORCL, ITRI, CSX, ABB, GILD, BKS, BYD, CCO, CIE, DTG, HL, JAKK, M, MDT, PXD, SKS, WLK, THLD, CORT, GTXI, CHTP, WMT, WFT)

US markets opened higher this morning and traded higher for most of the day. The DJIA briefly rose above 13,000 for the first time in nearly 3 years. But in ...
Read Full Story »

Second Look: Chelsea Not Dead Yet (CHTP)

Chelsea Therapeutics International Ltd. (NASDAQ: CHTP) looks dead.  In all actually, there is still some hope here.  Ultimately, the drug under question could be approved even if the FDA panel ...
Read Full Story »